Home » Author Archive
International Seaways Inc (NYSE:INSW) CFO Sells $16,350.00 in Stock
International Seaways Inc (NYSE:INSW) CFO Jeffrey Pribor sold 1,000 shares of the business’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $16.35, for a total transaction of $16,350.00.
Jeffrey Pribor also recently made the following trade(s):
On Monday, June 1st, Jeffrey Pribor sold 1,000 shares of International Seaways stock. The stock was sold at an average price of $22.87, for a total transaction of $22,870.00.
On Friday, May 1st, Jeffrey Pribor sold 1,000 shares of International Seaways...
Chemung Financial (NASDAQ:CHMG) Upgraded at Zacks Investment Research
Zacks Investment Research upgraded shares of Chemung Financial (NASDAQ:CHMG) from a strong sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports.
According to Zacks, “CHEMUNG FINANCIAL CORP. is a bank holding company, engaged thru the bank in full-service commercial and consumer banking and trust business. “
Other equities research analysts have also issued reports about the company. ValuEngine upgraded Chemung Financial from a sell rating to a hold rating in a research report on Monday, May 18th....
McGrath RentCorp (NASDAQ:MGRC) Lifted to “Hold” at Zacks Investment Research
Zacks Investment Research upgraded shares of McGrath RentCorp (NASDAQ:MGRC) from a strong sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports.
According to Zacks, “McGrath RentCorp is comprised of three business segments: Mobile Modular Management Corporation, their modular building rental group, RenTelco, their electronic test equipment rental group, and Enviroplex, their majority-owned subsidiary classroom manufacturing business. MMMC rents and sells modular buildings and accessories to fulfill customers’...
International Money Express (NASDAQ:IMXI) Raised to Hold at Zacks Investment Research
Zacks Investment Research upgraded shares of International Money Express (NASDAQ:IMXI) from a sell rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports.
According to Zacks, “International Money Express Inc. offer wire transfer and other processing services to customers through network of sending and paying agents located primarily in the District of Columbia and Puerto Rico as well as throughout Latin America. International Money Express Inc., formerly known as FinTech Acquisition Corp. II, is headquartered...
Mediwound’s (MDWD) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Mediwound (NASDAQ:MDWD) in a research note released on Wednesday, AnalystRatings.com reports. They currently have a $5.50 target price on the biopharmaceutical company’s stock.
A number of other research analysts have also recently commented on MDWD. Zacks Investment Research raised shares of Mediwound from a hold rating to a buy rating and set a $3.00 target price on the stock in a research report on Saturday, June 20th. Oppenheimer reissued a buy rating and set a $7.00 target price on...
Cellectar Biosciences (NASDAQ:CLRB) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB) in a report published on Wednesday morning, AnalystRatings.com reports. The brokerage issued an outperform rating and a $5.00 target price on the biopharmaceutical company’s stock. Oppenheimer also issued estimates for Cellectar Biosciences’ Q2 2020 earnings at ($0.27) EPS, Q3 2020 earnings at ($0.18) EPS, Q4 2020 earnings at ($0.19) EPS, FY2020 earnings at ($0.93) EPS and FY2021 earnings at ($0.89) EPS.
CLRB has been the topic of several other research reports....
ICU Medical (NASDAQ:ICUI) Upgraded at BidaskClub
BidaskClub upgraded shares of ICU Medical (NASDAQ:ICUI) from a sell rating to a hold rating in a research report sent to investors on Wednesday, BidAskClub reports.
Several other research firms also recently issued reports on ICUI. Zacks Investment Research downgraded ICU Medical from a hold rating to a sell rating in a research note on Wednesday, June 3rd. ValuEngine downgraded ICU Medical from a buy rating to a hold rating in a research note on Monday, April 27th. CJS Securities upgraded ICU Medical from a market perform rating to an outperform...
National Instruments (NASDAQ:NATI) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of National Instruments (NASDAQ:NATI) from a hold rating to a buy rating in a research note issued to investors on Wednesday, Zacks.com reports. The firm currently has $43.00 price target on the technology company’s stock.
According to Zacks, “National Instruments Corporation, or NI, is an American multinational company with international operation. It is a producer of automated test equipment and virtual instrumentation software. Common applications include data acquisition, instrument control...
CVS Health (NYSE:CVS) Research Coverage Started at SVB Leerink
SVB Leerink assumed coverage on shares of CVS Health (NYSE:CVS) in a research note issued to investors on Wednesday morning, 24/7 WallStreet reports. The firm issued a market perform rating and a $72.00 target price on the pharmacy operator’s stock. SVB Leerink also issued estimates for CVS Health’s Q4 2020 earnings at $1.58 EPS and FY2022 earnings at $8.00 EPS.
Several other equities analysts also recently commented on CVS. Morgan Stanley increased their target price on CVS Health from $71.00 to $77.00 and gave the company an overweight...
Benefytt Technologies (NASDAQ:BFYT) Research Coverage Started at SVB Leerink
SVB Leerink initiated coverage on shares of Benefytt Technologies (NASDAQ:BFYT) in a research note released on Wednesday morning, BenzingaRatingsTable reports. The brokerage issued an outperform rating and a $27.50 price objective on the stock.
BFYT has been the topic of several other reports. Cantor Fitzgerald restated a buy rating and issued a $75.00 price objective on shares of Benefytt Technologies in a report on Wednesday, June 17th. Canaccord Genuity restated a buy rating on shares of Benefytt Technologies in a report on Monday, May 11th....
Humana (NYSE:HUM) Research Coverage Started at SVB Leerink
SVB Leerink began coverage on shares of Humana (NYSE:HUM) in a report published on Wednesday morning, BenzingaRatingsTable reports. The brokerage issued an outperform rating and a $465.00 target price on the insurance provider’s stock. SVB Leerink also issued estimates for Humana’s Q2 2020 earnings at $10.07 EPS, Q3 2020 earnings at $2.09 EPS, Q4 2020 earnings at $1.35 EPS and FY2022 earnings at $25.55 EPS.
A number of other brokerages have also recently commented on HUM. Zacks Investment Research cut Humana from a buy rating to a hold...
Virtu Financial (NASDAQ:VIRT) PT Lowered to $26.00 at Morgan Stanley
Virtu Financial (NASDAQ:VIRT) had its target price trimmed by Morgan Stanley from $27.00 to $26.00 in a research report sent to investors on Wednesday, BenzingaRatingsTable reports. The brokerage currently has an equal weight rating on the financial services provider’s stock.
Other equities research analysts have also issued reports about the stock. Zacks Investment Research raised shares of Virtu Financial from a hold rating to a buy rating and set a $25.00 price target on the stock in a report on Saturday, March 14th. JPMorgan Chase &...
BTIG Research Raises Upwork (NASDAQ:UPWK) Price Target to $16.00
Upwork (NASDAQ:UPWK) had its price objective lifted by BTIG Research from $14.00 to $16.00 in a research note issued to investors on Wednesday morning, The Fly reports. They currently have a buy rating on the stock.
Several other equities analysts also recently issued reports on the company. Zacks Investment Research raised Upwork from a sell rating to a hold rating in a research report on Wednesday, June 17th. BidaskClub raised shares of Upwork from a buy rating to a strong-buy rating in a report on Tuesday. Finally, JMP Securities lowered their...
KeyCorp Boosts Atlassian (NASDAQ:TEAM) Price Target to $201.00
Atlassian (NASDAQ:TEAM) had its price target increased by KeyCorp from $163.00 to $201.00 in a report released on Wednesday, BenzingaRatingsTable reports. They currently have an overweight rating on the technology company’s stock.
A number of other research analysts have also recently commented on the company. SunTrust Banks reaffirmed a buy rating on shares of Atlassian in a research note on Tuesday, April 14th. Goldman Sachs Group upped their target price on Atlassian from $194.00 to $219.00 and gave the company a buy rating in a research...
Mitek Systems (NASDAQ:MITK) Downgraded by Zacks Investment Research
Zacks Investment Research lowered shares of Mitek Systems (NASDAQ:MITK) from a strong-buy rating to a hold rating in a report released on Wednesday morning, Zacks.com reports.
According to Zacks, “Mitek Systems, Inc. is primarily engaged in the development and sale of software products with particular focus on intelligent character recognition and forms processing technology, products and services for the document imaging markets. They develop, market and support what they believe to be the most accurate Automated Document Recognition (ADR)...
Denali Therapeutics (NASDAQ:DNLI) Cut to “Hold” at BidaskClub
BidaskClub lowered shares of Denali Therapeutics (NASDAQ:DNLI) from a buy rating to a hold rating in a research report released on Wednesday, BidAskClub reports.
A number of other brokerages have also recently issued reports on DNLI. Morgan Stanley decreased their price objective on shares of Denali Therapeutics from $30.00 to $28.00 and set an overweight rating for the company in a report on Wednesday, April 15th. Evercore ISI upgraded shares of Denali Therapeutics from an in-line rating to an outperform rating and set a $20.00 price target for...
BidaskClub Lowers 1-800-Flowers.Com (NASDAQ:FLWS) to Hold
BidaskClub cut shares of 1-800-Flowers.Com (NASDAQ:FLWS) from a buy rating to a hold rating in a research report report published on Wednesday, BidAskClub reports.
A number of other equities research analysts also recently weighed in on FLWS. Benchmark raised their target price on shares of 1-800-Flowers.Com from $23.00 to $28.00 and gave the company a buy rating in a research note on Friday, June 19th. DA Davidson downgraded shares of 1-800-Flowers.Com from a neutral rating to an underperform rating and set a $17.00 price target on the stock. in...
JPMorgan Chase & Co. Boosts Cummins (NYSE:CMI) Price Target to $171.00
Cummins (NYSE:CMI) had its price target hoisted by JPMorgan Chase & Co. from $145.00 to $171.00 in a report issued on Wednesday, The Fly reports. They currently have a neutral rating on the stock.
CMI has been the topic of several other reports. Oppenheimer reaffirmed a hold rating on shares of Cummins in a report on Tuesday, April 28th. Morgan Stanley upped their price objective on Cummins from $125.00 to $152.00 and gave the stock an equal weight rating in a report on Wednesday, April 29th. BMO Capital Markets upped their price objective...
Anterix (NASDAQ:ATEX) PT Lowered to $50.00 at Morgan Stanley
Anterix (NASDAQ:ATEX) had its price objective cut by Morgan Stanley from $51.00 to $50.00 in a report released on Wednesday, AnalystRatings.com reports. They currently have an equal weight rating on the stock.
A number of other analysts have also commented on the stock. B. Riley boosted their price objective on shares of Anterix from $59.00 to $75.00 and gave the stock a buy rating in a research report on Friday, May 22nd. Craig Hallum boosted their target price on shares of Anterix from $80.00 to $100.00 and gave the stock a buy rating in a report...
Green Plains (NASDAQ:GPRE) Cut to “Hold” at Zacks Investment Research
Zacks Investment Research cut shares of Green Plains (NASDAQ:GPRE) from a buy rating to a hold rating in a report issued on Wednesday, Zacks.com reports.
According to Zacks, “Green Plains Inc. is vertically integrated producer, marketer and distributer of ethanol. The company operates through four segments: Ethanol Production, Corn Oil Production, Agribusiness, and Marketing and Distribution. It produces ethanol and co-products, such as wet, modified wet or dried distillers grains, as well as extracts non-edible corn oil. The company is also...
KeyCorp Reaffirms Buy Rating for Life Storage (NYSE:LSI)
KeyCorp reaffirmed their buy rating on shares of Life Storage (NYSE:LSI) in a research note published on Wednesday morning, TipRanks reports. The brokerage currently has a $106.00 target price on the real estate investment trust’s stock. KeyCorp also issued estimates for Life Storage’s FY2020 earnings at $5.83 EPS.
A number of other equities analysts have also commented on the company. Zacks Investment Research lowered Life Storage from a buy rating to a hold rating in a research note on Saturday, April 18th. Stifel Nicolaus increased...
Korn Ferry (NYSE:KFY) Announces Quarterly Earnings Results
Korn Ferry (NYSE:KFY) released its earnings results on Thursday. The business services provider reported $0.60 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.21, MarketWatch Earnings reports. The company had revenue of $440.50 million during the quarter, compared to analysts’ expectations of $436.38 million. Korn Ferry had a net margin of 5.31% and a return on equity of 12.84%. The business’s revenue was down 10.2% on a year-over-year basis. During the same quarter last year, the business earned...
Lloyds Banking Group (NYSE:LYG) Stock Rating Upgraded by Investec
Lloyds Banking Group (NYSE:LYG) was upgraded by stock analysts at Investec from a “hold” rating to a “buy” rating in a report released on Thursday, MarketBeat.com reports.
Several other equities research analysts also recently issued reports on LYG. Royal Bank of Canada reaffirmed an “outperform” rating on shares of Lloyds Banking Group in a research report on Tuesday, May 5th. Morgan Stanley reaffirmed an “overweight” rating on shares of Lloyds Banking Group in a research report on Friday, June...
Hibbett Sports (NASDAQ:HIBB) Rating Increased to Buy at Bank of America
Hibbett Sports (NASDAQ:HIBB) was upgraded by equities researchers at Bank of America from an “underperform” rating to a “buy” rating in a report issued on Thursday, Marketbeat.com reports. The brokerage presently has a $30.00 price objective on the stock, up from their prior price objective of $10.00. Bank of America‘s price target suggests a potential upside of 30.55% from the company’s previous close.
A number of other research analysts have also commented on the stock. BidaskClub upgraded shares of Hibbett...
Luxfer (NYSE:LXFR) Downgraded by Zacks Investment Research
Zacks Investment Research lowered shares of Luxfer (NYSE:LXFR) from a buy rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports.
According to Zacks, “Luxfer Holdings PLC is a materials technology company specialising in the design, manufacture and supply of high-performance materials, components and gas cylinders. The company had two divisions, Elektron and Gas Cylinders. The Elektron division focuses on speciality materials based on magnesium, zirconium and rare earths. The Gas Cylinders division manufactures...
SunTrust Banks Initiates Coverage on Tabula Rasa HealthCare (NASDAQ:TRHC)
Analysts at SunTrust Banks started coverage on shares of Tabula Rasa HealthCare (NASDAQ:TRHC) in a research note issued on Thursday, Marketbeat.com reports. The brokerage set a “buy” rating and a $72.00 price target on the stock. SunTrust Banks’ price target points to a potential upside of 26.21% from the company’s previous close.
Other research analysts have also issued reports about the stock. Cantor Fitzgerald decreased their price objective on shares of Tabula Rasa HealthCare from $85.00 to $83.00 and set an “overweight”...
Amalgamated Bank (NASDAQ:AMAL) Raised to “Buy” at Zacks Investment Research
Zacks Investment Research upgraded shares of Amalgamated Bank (NASDAQ:AMAL) from a hold rating to a buy rating in a research report report published on Wednesday morning, Zacks.com reports. They currently have $14.00 price target on the stock.
According to Zacks, “Amalgamated Bank provides personal and commercial banking products and services to working families, unions, commercial real estate industries, healthcare markets, institutional investors, law firms, non-profits and political organizations. The company offers checking, savings,...
Meghan Tuohig Sells 500 Shares of Overstock.com Inc (NASDAQ:OSTK) Stock
Overstock.com Inc (NASDAQ:OSTK) insider Meghan Tuohig sold 500 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $30.00, for a total transaction of $15,000.00. Following the transaction, the insider now owns 14,735 shares in the company, valued at approximately $442,050. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Meghan Tuohig also recently made the following trade(s):
On Friday, June 19th,...
Marshall Witt Sells 284 Shares of SYNNEX Co. (NYSE:SNX) Stock
SYNNEX Co. (NYSE:SNX) CFO Marshall Witt sold 284 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $119.20, for a total value of $33,852.80. Following the completion of the transaction, the chief financial officer now owns 14,613 shares of the company’s stock, valued at approximately $1,741,869.60. The sale was disclosed in a document filed with the SEC, which is available through this link.
Marshall Witt also recently made the following trade(s):
On Friday, May 1st,...
Square (NYSE:SQ) Raised to Buy at Rosenblatt Securities
Rosenblatt Securities upgraded shares of Square (NYSE:SQ) from a neutral rating to a buy rating in a research report report published on Wednesday morning, BenzingaRatingsTable reports. They currently have $121.00 target price on the technology company’s stock, up from their previous target price of $69.00.
Several other brokerages also recently commented on SQ. Nomura Securities raised Square from a reduce rating to a neutral rating and set a $49.00 price objective on the stock in a research report on Wednesday, March 25th. Bank of America...
Diageo (LON:DGE) PT Lowered to GBX 3,220 at Barclays
Diageo (LON:DGE) had its price objective cut by Barclays from GBX 3,230 ($39.75) to GBX 3,220 ($39.63) in a report released on Wednesday morning, Borsen Zeitung reports. They currently have an overweight rating on the stock.
Other research analysts also recently issued reports about the stock. Jefferies Financial Group set a GBX 2,200 ($27.07) price objective on shares of Diageo and gave the company a sell rating in a research report on Thursday, May 28th. Credit Suisse Group cut shares of Diageo to a neutral rating and dropped their target price...
Jefferies Financial Group Reaffirms Buy Rating for Provident Financial (LON:PFG)
Jefferies Financial Group reaffirmed their buy rating on shares of Provident Financial (LON:PFG) in a research note published on Wednesday, ThisIsMoney.Co.Uk reports.
PFG has been the subject of a number of other research reports. Barclays cut their price objective on shares of Provident Financial from GBX 510 ($6.28) to GBX 405 ($4.98) and set an overweight rating for the company in a research report on Thursday, May 28th. JPMorgan Chase & Co. cut their price objective on shares of Provident Financial from GBX 240 ($2.95) to GBX 200 ($2.46)...
MCCORMICK & CO /SH NV (NYSE:MKC) Director Sells $631,750.00 in Stock
MCCORMICK & CO /SH NV (NYSE:MKC) Director Maritza Gomez Montiel sold 3,500 shares of the business’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $180.50, for a total transaction of $631,750.00. Following the completion of the sale, the director now owns 5,590 shares in the company, valued at $1,008,995. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
NYSE:MKC opened at $181.61 on Friday. The company has a debt-to-equity...
Dynavax Technologies (NASDAQ:DVAX) Upgraded to Buy by Zacks Investment Research
Zacks Investment Research upgraded shares of Dynavax Technologies (NASDAQ:DVAX) from a hold rating to a buy rating in a research note released on Tuesday morning, Zacks.com reports. They currently have $9.50 price objective on the biopharmaceutical company’s stock.
According to Zacks, “Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses...
Goldman Sachs Group Trims BP (LON:BP) Target Price to GBX 530
BP (LON:BP) had its target price cut by Goldman Sachs Group from GBX 550 ($6.77) to GBX 530 ($6.52) in a research note released on Wednesday morning, Borsen Zeitung reports. They currently have a conviction-buy rating on the oil and gas exploration company’s stock.
Several other equities research analysts have also issued reports on BP. Barclays boosted their price target on shares of BP from GBX 380 ($4.68) to GBX 400 ($4.92) and gave the company an overweight rating in a report on Wednesday. Kepler Capital Markets reissued a buy rating...
Norsk Hydro ASA (OTCMKTS:NHYDY) Downgraded by Zacks Investment Research
Zacks Investment Research cut shares of Norsk Hydro ASA (OTCMKTS:NHYDY) from a buy rating to a sell rating in a research report released on Wednesday morning, Zacks.com reports.
According to Zacks, “Norsk Hydro ASA is an aluminium company with production, sales and trading activities. The company’s operating segment consists of Bauxite & Alumina, Primary Metal, Metal Markets, Rolled Products, Energy and Other and eliminations. Norsk Hydro ASA is headquartered in Oslo, Norway. “
Several other equities analysts have also...
Hammerson (LON:HMSO) Cut to Sell at Panmure Gordon
Panmure Gordon lowered shares of Hammerson (LON:HMSO) to a sell rating in a report published on Wednesday morning, Stock Target Advisor reports.
A number of other analysts also recently commented on HMSO. Jefferies Financial Group decreased their target price on Hammerson from GBX 188 ($2.31) to GBX 59 ($0.73) and set an underperform rating on the stock in a research report on Thursday, April 2nd. JPMorgan Chase & Co. decreased their target price on Hammerson from GBX 300 ($3.69) to GBX 185 ($2.28) and set a neutral rating on the stock in a...
Coats Group (LON:COA) Earns “Buy” Rating from Peel Hunt
Peel Hunt reaffirmed their buy rating on shares of Coats Group (LON:COA) in a report released on Wednesday, ThisIsMoney.Co.Uk reports.
Other equities research analysts also recently issued research reports about the company. HSBC upgraded Coats Group to a buy rating and reduced their target price for the company from GBX 69 ($0.85) to GBX 62 ($0.76) in a research report on Wednesday, May 6th. Berenberg Bank lifted their target price on Coats Group from GBX 55 ($0.68) to GBX 65 ($0.80) and gave the company a buy rating in a research report on Thursday,...
Datadog (NASDAQ:DDOG) Director Sells $3,091,125.00 in Stock
Datadog (NASDAQ:DDOG) Director Julie Richardson sold 37,500 shares of Datadog stock in a transaction on Monday, June 29th. The shares were sold at an average price of $82.43, for a total value of $3,091,125.00. Following the completion of the transaction, the director now owns 39,801 shares of the company’s stock, valued at $3,280,796.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
DDOG opened at $89.59 on Friday. The stock has a 50-day moving average price...
Magenta Therapeutics Inc (NASDAQ:MGTA) Director Acquires $10,000,000.00 in Stock
Magenta Therapeutics Inc (NASDAQ:MGTA) Director Bruce Booth bought 1,250,000 shares of the firm’s stock in a transaction dated Monday, June 29th. The shares were acquired at an average price of $8.00 per share, with a total value of $10,000,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Shares of NASDAQ MGTA opened at $7.97 on Friday. The company’s 50-day simple moving average is $9.19 and its 200-day simple moving average is $10.61. Magenta...
National Express Group (OTCMKTS:NXPGF) Downgraded by Zacks Investment Research
Zacks Investment Research cut shares of National Express Group (OTCMKTS:NXPGF) from a hold rating to a sell rating in a report issued on Wednesday morning, Zacks.com reports.
According to Zacks, “National Express Group plc is a transport operator. It provides bus, coach and rail services primarily in the UK, Continental Europe, North Africa, North America and the Middle East. National Express Group plc is based in Birmingham, United Kingdom. “
Several other analysts have also weighed in on the company. Royal Bank of Canada restated...
SolGold’s (SOLG) “Buy” Rating Reiterated at Peel Hunt
Peel Hunt restated their buy rating on shares of SolGold (LON:SOLG) in a report issued on Wednesday morning, ThisIsMoney.Co.Uk reports.
Separately, Liberum Capital lowered their price target on SolGold from GBX 63 ($0.78) to GBX 58 ($0.71) and set a buy rating on the stock in a report on Wednesday.
LON SOLG opened at GBX 20.20 ($0.25) on Wednesday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.61. SolGold has a 52-week low of GBX 10 ($0.12) and a 52-week high of GBX 32 ($0.39). The business’s...
Peel Hunt Reaffirms Buy Rating for Sirius Real Estate (LON:SRE)
Peel Hunt reissued their buy rating on shares of Sirius Real Estate (LON:SRE) in a research note issued to investors on Wednesday morning, ThisIsMoney.Co.Uk reports.
Separately, Berenberg Bank reissued a buy rating and set a GBX 91 ($1.12) price objective on shares of Sirius Real Estate in a research note on Monday, June 1st.
Shares of Sirius Real Estate stock opened at GBX 78.90 ($0.97) on Wednesday. The firm’s 50-day simple moving average is GBX 74.23 and its 200-day simple moving average is GBX 78.11. Sirius Real Estate has a 1 year low...
Sylvania Platinum (LON:SLP) Earns “Buy” Rating from Liberum Capital
-logo.jpg&h=100&w=100&zc=1){kind=logo}
Liberum Capital reaffirmed their buy rating on shares of Sylvania Platinum (LON:SLP) in a research report released on Wednesday morning, ThisIsMoney.Co.Uk reports.
Shares of Sylvania Platinum stock opened at GBX 38 ($0.47) on Wednesday. The company has a debt-to-equity ratio of 0.42, a current ratio of 7.73 and a quick ratio of 7.07. Sylvania Platinum has a 1 year low of GBX 24 ($0.30) and a 1 year high of GBX 67 ($0.82). The business has a 50 day moving average price of GBX 46.03 and a 200 day moving average price of GBX 43.34. The company has...
XPS Pensions Group (LON:XPS) Earns Outperform Rating from Royal Bank of Canada
Royal Bank of Canada reissued their outperform rating on shares of XPS Pensions Group (LON:XPS) in a research note published on Wednesday, Stock Target Advisor reports.
Separately, Liberum Capital reiterated a buy rating on shares of XPS Pensions Group in a research report on Thursday, June 25th.
XPS Pensions Group stock opened at GBX 117 ($1.44) on Wednesday. The stock has a market cap of $239.71 million and a PE ratio of 32.64. The company has a debt-to-equity ratio of 54.26, a quick ratio of 1.85 and a current ratio of 1.85. XPS Pensions Group...
Q3 2021 EPS Estimates for Texas Capital Bancshares Inc (NASDAQ:TCBI) Decreased by Analyst
Texas Capital Bancshares Inc (NASDAQ:TCBI) – Equities researchers at Piper Sandler reduced their Q3 2021 earnings per share estimates for Texas Capital Bancshares in a note issued to investors on Wednesday, July 1st. Piper Sandler analyst B. Milsaps now expects that the bank will earn $0.71 per share for the quarter, down from their previous forecast of $0.76. Piper Sandler has a “Neutral” rating and a $26.00 price objective on the stock. Piper Sandler also issued estimates for Texas Capital Bancshares’ Q4 2021 earnings...
Rockwell Medical (NASDAQ:RMTI) and Integrated BioPharma (NASDAQ:INBP) Critical Survey
Rockwell Medical (NASDAQ:RMTI) and Integrated BioPharma (OTCMKTS:INBP) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends.
Institutional and Insider Ownership
21.1% of Rockwell Medical shares are owned by institutional investors. 4.7% of Rockwell Medical shares are owned by company insiders. Comparatively, 71.3% of Integrated BioPharma shares are owned by...
Research Analysts Offer Predictions for 9 Meters Biopharma, Inc.’s FY2020 Earnings (NASDAQ:NMTR)
9 Meters Biopharma, Inc. (NASDAQ:NMTR) – SunTrust Banks issued their FY2020 earnings per share (EPS) estimates for shares of 9 Meters Biopharma in a report issued on Tuesday, June 30th. SunTrust Banks analyst S. Devarakonda forecasts that the company will post earnings of ($0.51) per share for the year. SunTrust Banks currently has a “Buy” rating and a $5.00 price objective on the stock. SunTrust Banks also issued estimates for 9 Meters Biopharma’s FY2021 earnings at ($0.24) EPS, FY2022 earnings at ($0.29) EPS, FY2023...
Restaurant Brands International Inc (TSE:QSR) Expected to Earn FY2020 Earnings of $2.79 Per Share
Restaurant Brands International Inc (TSE:QSR) (NYSE:QSR) – Research analysts at Piper Sandler boosted their FY2020 earnings per share estimates for shares of Restaurant Brands International in a research report issued to clients and investors on Monday, June 29th. Piper Sandler analyst N. Regan now expects that the company will post earnings per share of $2.79 for the year, up from their prior estimate of $2.77. Piper Sandler also issued estimates for Restaurant Brands International’s Q4 2020 earnings at $0.97 EPS, Q1 2021 earnings...
Rapid7 (NASDAQ:RPD) Raised to “Hold” at BidaskClub
BidaskClub upgraded shares of Rapid7 (NASDAQ:RPD) from a sell rating to a hold rating in a report issued on Tuesday, BidAskClub reports.
RPD has been the topic of several other reports. Monness Crespi & Hardt lowered their price objective on shares of Rapid7 from $72.00 to $60.00 and set a buy rating on the stock in a research report on Wednesday, April 29th. Raymond James lifted their price objective on shares of Rapid7 from $53.00 to $64.00 and gave the stock a strong-buy rating in a research report on Friday, May 8th. Morgan Stanley lifted...
